Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, today announced a strategic collaboration with Inflect Health, the new nationwide, multispecialty investment and innovation hub formed by Vituity.
"The fact that we can differentiate between all three stroke subtypes makes us stronger than our competition," Sense Neuro Diagnostics CEO Geoff Klass recently told reporter Liz Engel of CincyInno. "We feel very comfortable with our position. When it comes to in-hospital monitoring, we’re the only company developing a product to handle that."
TechOhio: This Cincinnati Startup is Creating a Non-Invasive Way to Diagnose and Monitor Stroke and Brain Injuries
When someone suffers a stroke, time to proper care is critical. As Sense Neuro CTO and medical co-founder George Shaw, MD tells TechOhio, "...Time equals brain cells, and you don’t want any detours on the way."
An underdog from the start of CincyInno's 2021 Tech Madness bracket challenge, Sense Neuro Diagnostics was the last startup standing after five head-to-head matchups and more than 3000 votes.
Sense Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, announced the initiation of a multicenter pivotal trial to evaluate the safety and efficacy of a non-invasive brain scanner to monitor intracranial hemorrhage (ICH) in an acute hospital setting.
Sense Diagnostics is honored to be named Business Center Client of the Year by HCDC, Inc, an economic development organization that runs a technology business incubator, is an SBA lender, and is the Economic Development Office for Hamilton County, Ohio.
StartUs Insights analyzed 90 companies before selecting five, with Sense as the sole US representative. Every day, #stroke and brain injury patients suffer disability and death that might have been avoided if they’d gotten to the proper level of care facility sooner. Our team is working tirelessly to develop technology to address this problem and improve outcomes for patients and hospitals.
Congratulations to Geoffrey Klass, CEO of Sense Neuro Diagnostics on being selected as an Innovation Leader at the LSI 2021 Emerging Medtech Summit. For the second year in a row, Geoff Klass will be presenting to an exceptional group of investors and strategics.
Sense Neuro Diagnostics co-founder and CTO Dr. George Shaw, MD, will present clinical findings at the Society for Academic Emergency Medicine’s 2021 virtual meeting in May. The abstract accepted for presentation, “Pilot study of a non-invasive RF method to determine stroke subtype,” details Sense’s first-in human stroke differentiation study.